[Prognostic significance of nuclear DNA content in breast cancer]. 1990

T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
Department of General and Abdominal Surgery, Osaka Medical College.

The relationship between nuclear DNA content determined by cytofluorometry in the primary focus of breast cancer and the survival rate was analyzed to clarify the prognostic significance of nuclear DNA content in breast cancer. The relationships of the ploidy pattern and the frequency of polyploid cells (4c or above) with the survival rate were studied in patients who underwent extended radical mastectomy and were comparable in the clinical stage and other prognostic factors. The survival rate was significantly lower in those of the non-diploid type showing no prominent peak at 2c or those in whom the frequency of polyploid cells was more than 30% than in those of the diploid type with a prominent peak at 2c or those showing few polyploid cells, even when the disease stage (Stage II by TNM classification and stage III by Tnm classification), histological lymph node metastasis (n (+), n1 beta), and histological type (papillotubular carcinoma, scirrhous carcinoma) were identical. From these findings, nuclear DNA content is considered to be a parameter of the malignancy of breast cancer and to have clinical significance as an important prognostic factor.

UI MeSH Term Description Entries
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
February 2000, Annals of diagnostic pathology,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
September 1991, The Australian and New Zealand journal of surgery,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
February 1987, The British journal of surgery,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
December 1980, Analytical and quantitative cytology,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
November 1993, Zhonghua wai ke za zhi [Chinese journal of surgery],
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
March 1992, Cancer,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
May 1984, Cancer research,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
July 1991, International journal of cancer,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
November 1989, British journal of cancer,
T Nishi, and K Okajima, and T Taguchi, and T Ryo, and H Mizutani, and Y Kawashima, and T Sekimoto
December 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!